
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded tablet containing sildenafil citrate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing sildenafil are listed in tablet, powder for suspension, film and injection forms.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Sildenafil is a PDE5 inhibitor, commonly compounded into oral troches, sublingual tablets, oral suspensions and topical preparations.
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor. When sexual stimulation releases nitric oxide in penile tissue, a messenger called cGMP relaxes smooth muscle and lets blood flow in; PDE5 breaks cGMP down, and sildenafil blocks that breakdown so the signal lasts longer. It has no effect without sexual stimulation. The same pathway relaxes blood vessels in the lungs. Manufactured products include Viagra tablets, FDA-approved for erectile dysfunction, and Revatio tablets, oral suspension and injection, approved for pulmonary arterial hypertension to improve exercise ability. A prescriber might order sildenafil compounded when a patient needs a troche, sublingual or liquid form, a strength between the manufactured tablets, a preparation free of a dye or other allergen, or a combination with another ingredient in one dosage form. Compounded preparations are not FDA-approved and require a prescription.
Sildenafil has no FDA boxed warning, but it must never be combined with nitrates such as nitroglycerin or isosorbide, including "poppers," or with riociguat, because the combination can cause a dangerous drop in blood pressure. Do not use it if you are allergic to sildenafil. Ritonavir, ketoconazole, itraconazole, erythromycin and cimetidine raise sildenafil levels; alpha-blockers and blood pressure medicines add to its blood-pressure-lowering effect. Heart attack and stroke have been reported in men with existing heart disease, so tell your prescriber about any heart condition, abnormal blood pressure, eye disease, bleeding disorders or sickle cell anemia. Get care right away for sudden vision or hearing loss, chest pain, or an erection lasting more than 4 hours. Viagra is not indicated for women; LactMed reports sildenafil passes poorly into breast milk with no expected infant effects. Common side effects are headache, flushing, upset stomach, nasal congestion, back pain and a blue tinge to vision. Talk to your prescriber or pharmacist about any side effect that worries you.
Sildenafil is a competitive, selective PDE5 inhibitor that prolongs cGMP signaling in the corpus cavernosum and in pulmonary vascular smooth muscle. Oral absorption is rapid with median Tmax about 60 minutes fasted and mean absolute bioavailability of 41%; a high-fat meal delays Tmax and lowers Cmax. Sildenafil and its active N-desmethyl metabolite are about 96% protein bound, metabolism is mainly CYP3A4 with a minor CYP2C9 contribution, and the terminal half-life is about 4 hours. Exposure rises with age over 65, hepatic impairment, severe renal impairment and CYP3A4 inhibitors; ritonavir increases AUC about 11-fold. Labeled indications: Viagra for erectile dysfunction; Revatio (tablets, oral suspension, injection) for WHO Group I pulmonary arterial hypertension in adults and in pediatric patients 1 to 17 years. Beyond the label, StatPearls lists use for secondary Raynaud phenomenon, female sexual arousal disorder and altitude-induced hypoxemia. Dosing and timing are per prescriber, with lower starting exposure advised for the special populations above. Monitoring is largely clinical: blood pressure and pulse after initiation or when adding CYP3A4 inhibitors, visual and auditory symptoms, priapism, and pulmonary edema in PAH patients with veno-occlusive disease. Sildenafil is not a controlled substance.
Swallow the tablet whole with water unless your label says to chew it or dissolve it. Do not crush or split it unless your pharmacist says that is appropriate. Take it at the times on your prescription label and call the pharmacy with any questions.
Tablets are nonaqueous, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in a closed container at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 tablet by mouth